Garrafa Emirena, Segala Agnese, Vezzoli Marika, Bottani Emanuela, Zanini Barbara, Vetturi Alice, Bracale Renata, Ricci Chiara, Valerio Alessandra
Department of Laboratory Diagnostics, ASST Spedali Civili, 25123 Brescia, Italy.
Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Diagnostics (Basel). 2023 Jul 13;13(14):2363. doi: 10.3390/diagnostics13142363.
Non-alcoholic fatty liver disease (NAFLD) is a health emergency worldwide due to its high prevalence and the lack of specific therapies. Noninvasive biomarkers supporting NAFLD diagnosis are urgently needed. Liver mitochondrial dysfunction is a central NAFLD pathomechanism that changes throughout disease progression. Blood-cell bioenergetics reflecting mitochondrial organ dysfunction is emerging for its potential applications in diagnostics. We measured real-time mitochondrial respirometry in peripheral blood mononuclear cells (PBMCs), anthropometric parameters, routine blood analytes, and circulating cytokines from a cohort of NAFLD patients (N = 19) and non-NAFLD control subjects (N = 18). PBMC basal respiration, ATP-linked respiration, maximal respiration, and spare respiratory capacity were significantly reduced in NAFLD compared to non-NAFLD cases. Correlation plots were applied to visualize relationships between known or potential NAFLD-related biomarkers, while non-parametric methods were applied to identify which biomarkers are NAFLD predictors. Basal and ATP-linked mitochondrial respiration were negatively correlated with triglycerides and fasting insulin levels and HOMA index. Maximal and spare respiratory capacity were negatively correlated with IL-6 levels. All the mitochondrial respiratory parameters were positively correlated with HDL-cholesterol level and negatively correlated with fatty liver index. We propose including blood cell respirometry in panels of NAFLD diagnostic biomarkers to monitor disease progression and the response to current and novel therapies, including mitochondrial-targeted ones.
非酒精性脂肪性肝病(NAFLD)因其高患病率和缺乏特异性治疗方法,已成为全球范围内的一项健康紧急问题。迫切需要支持NAFLD诊断的非侵入性生物标志物。肝线粒体功能障碍是NAFLD的核心发病机制,且在疾病进展过程中会发生变化。反映线粒体器官功能障碍的血细胞生物能量学因其在诊断中的潜在应用而逐渐兴起。我们测量了一组NAFLD患者(N = 19)和非NAFLD对照受试者(N = 18)外周血单核细胞(PBMC)的实时线粒体呼吸测定、人体测量参数、常规血液分析物和循环细胞因子。与非NAFLD病例相比,NAFLD患者的PBMC基础呼吸、ATP相关呼吸、最大呼吸和备用呼吸能力显著降低。应用相关图来可视化已知或潜在的NAFLD相关生物标志物之间的关系,同时应用非参数方法来确定哪些生物标志物是NAFLD的预测指标。基础和ATP相关的线粒体呼吸与甘油三酯、空腹胰岛素水平和HOMA指数呈负相关。最大和备用呼吸能力与IL-6水平呈负相关。所有线粒体呼吸参数均与高密度脂蛋白胆固醇水平呈正相关,与脂肪肝指数呈负相关。我们建议将血细胞呼吸测定纳入NAFLD诊断生物标志物组中,以监测疾病进展以及对当前和新型治疗(包括针对线粒体的治疗)的反应。